Business
Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
SAN DIEGO and TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) today announced that Institutional Shareholder Services (“ISS”), a leading independent proxy advisory firm, has recommended that Aptose shareholders (“Shareholders”) vote ”FOR” a special resolution (the “Arrangement Resolution”) to approve the previously announced arrangement (the “Arrangement”) pursuant to which Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North
About this update from Hanmi Pharmaceutical Co., Ltd.
[{"type":"image","alt":"Aptose Biosciences, Inc.","displaySize":"","headline":null,"caption":"Aptose Biosciences, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":112,"url":"https://media.zenfs.com/en/globenewswire.com/b498b08d7b00ed826b23627f4658fc2d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dL_gapQCtA7xgCLWJXAd4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1Nw--/https://media.zenfs.com/en/globenewswire.com/b498b08d7b00ed826b23627f4658fc2d","width":300,"height":112}},"lazy":false},{"type":"text","content":"SAN DIEGO and TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) today announced that Institutional Shareholder Services (“ISS”), a leading independent proxy advisory firm, has recommended that Aptose shareholders (“Shareholders”) vote ”FOR” a special resolution (the “Arrangement Resolution”) to approve the previously announced arrangement (the “Arrangement”) pursuant to which Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North America Ltd., a wholly owned subsidiary of Hanmi (“Hanmi Purchaser” and together with Hanmi, the “Hanmi Purchasers”), will acquire all of the issued and outstanding common shares of Aptose (“Common Shares”) that are not currently owned or controlled by the Hanmi Purchasers or their respective affiliates.","length":806,"tagName":"p"},{"type":"text","content":"In making its recommendation that Shareholders vote FOR the Arrangement Resolution, ISS noted:","length":94,"tagName":"p"},{"type":"text","content":"“The offer price represents a premium to the unaffected price. In addition, the initial market reaction was positive, no other bidders have presented a superior proposal, and there has been no public opposition from non-Hanmi shareholders. The cash form of consideration provides liquidity and certainty of value to Aptose shareholders.”","length":337,"tagName":"p"},{"type":"text","content":"ISS also recommended approval of a continuance that will result in the Company continuing from a corporation governed under the Canada Business Corporations Act (“CBCA”) to a corporation continued under the Business Corporations Act (Alberta) (“ABCA”) (the “Continuance”). According to ISS, shareholder rights under the two statutes are largely similar and there would be no adverse impact on such rights on account of the Continuance...